Veena Mani, Sanjeeb Mukherjee &Amp;Amp; Sohini Das

Stories by Veena Mani, Sanjeeb Mukherjee &Amp;Amp; Sohini Das

Skoda India gears up for EV play with local push

Skoda India gears up for EV play with local push

Rediff.com   25 Apr 2025

Skoda Auto India, the Czech carmaker that has recently found success with its compact SUV Kylaq, says it remains committed to developing a fully localised electric vehicle (EV). The EV will be manufactured at its Chakan facility for both Indian market and exports.

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Rediff.com   12 Apr 2025

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.

How India's agri sector can tackle US tariffs

How India's agri sector can tackle US tariffs

Rediff.com   10 Apr 2025

India's policy for agriculture trade must move commodity-by-commodity to gain maximum benefits as US President Donald Trump's 26 per cent tariff on exports from the country take effect, said agriculture economist Ashok Gulati in a recent policy paper.

Skymet Predicts Normal Monsoon

Skymet Predicts Normal Monsoon

Rediff.com   9 Apr 2025

Skymet expects a good monsoon over western and southern India.

US tariff on Indian shrimp may go up from 8pc to 45 pc

US tariff on Indian shrimp may go up from 8pc to 45 pc

Rediff.com   7 Apr 2025

Seafood is one of India's largest agricultural exports after basmati rice and buffalo meat.

Used-car Sales Likely To Outpace New Ones In FY26

Used-car Sales Likely To Outpace New Ones In FY26

Rediff.com   4 Apr 2025

India's used car market, which has been growing steadily at 10-12 per cent over the last 2-3 years, is expected to reach $40 billion in FY26.

Indian Pharma Gets Relief from Trump's Tariffs

Indian Pharma Gets Relief from Trump's Tariffs

Rediff.com   4 Apr 2025

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com   2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

Young Buyers Power Lamborghini's India Drive

Young Buyers Power Lamborghini's India Drive

Rediff.com   31 Mar 2025

India ranks 6th in the Asia-Pacific region for the Italian super luxury carmaker.

Discounts are back at car dealerships

Discounts are back at car dealerships

Rediff.com   21 Mar 2025

Dealers said the discounts this March are higher than the same month in the previous year.

PV Sales Face Bleak Outlook in 2024-25

PV Sales Face Bleak Outlook in 2024-25

Rediff.com   20 Mar 2025

Major Indian carmakers are preparing for sluggish domestic PV sales growth of just 1-2 per cent in FY26.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com   20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

For Tesla, India is a challenge as well as opportunity

For Tesla, India is a challenge as well as opportunity

Rediff.com   19 Mar 2025

With India's EV penetration at just 2.5 per cent, the market presents an opportunity -- provided Tesla gets its pricing right.

From Tesla to Mercedes, luxury carmakers head South

From Tesla to Mercedes, luxury carmakers head South

Rediff.com   11 Mar 2025

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Return of winter chill may benefit wheat crop

Return of winter chill may benefit wheat crop

Rediff.com   6 Mar 2025

Wheat production during the current season is expected to be better than last year provided the weather remains favourable over the next few weeks, said senior industry executives. The weather had turned uncharacteristically hot in the latter half of last month, but owing to strong winds, the chill has returned in the last few days.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

India's Farm Sector Becoming Rainfall-Resistant

India's Farm Sector Becoming Rainfall-Resistant

Rediff.com   3 Mar 2025

'Rainfall does not appear to have a statistically significant impact on foodgrain production since the last few years, which contrasts with the traditional view of India's heavy reliance on monsoon rains for agriculture.'